Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts that cover Amphastar Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $28.38, which forecasts a 22.38% increase in the stock price over the next year. The lowest target is $22 and the highest is $35.

Price Target: $28.38 (+22.38%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$22	$28.38	$30	$35
Change	-5.13%	+22.38%	+29.37%	+50.93%

Analyst Ratings

The average analyst rating for Amphastar Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	2	1	1	2	2	2
Hold	3	4	4	4	4	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dennis Ding Jefferies	Jefferies	Strong Buy → Hold Downgrades $30 → $22	Strong Buy → Hold	Downgrades	$30 → $22	-5.13%	Apr 21, 2026
Glen Santangelo Barclays	Barclays	Hold Maintains $30 → $23	Hold	Maintains	$30 → $23	-0.82%	Apr 8, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $34 → $30	Buy	Maintains	$34 → $30	+29.37%	Feb 27, 2026
Serge Belanger Needham	Needham	Strong Buy Maintains $34 → $30	Strong Buy	Maintains	$34 → $30	+29.37%	Feb 27, 2026
Glen Santangelo Barclays	Barclays	Hold Initiates $30	Hold	Initiates	$30	+29.37%	Dec 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

769.53M

Increased by 6.90%

from 719.89M

Revenue Next Year

805.26M

Increased by 4.64%

from 769.53M

EPS This Year

3.35

Increased by 65.03%

from 2.03

EPS Next Year

3.56

Increased by 6.27%

from 3.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	437.77M	498.99M	644.40M	731.97M	719.89M	769.53M	805.26M
Revenue Growth	25.13%	13.98%	29.14%	13.59%	-1.65%	6.90%	4.64%
EPS	1.25	1.74	2.60	3.06	2.03	3.35	3.56
EPS Growth	4,090.97%	39.20%	49.43%	17.69%	-33.66%	65.03%	6.27%
Forward PE	-	-	-	-	-	6.92	6.51
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	811.9M	860.2M
Avg	769.5M	805.3M
Low	718.1M	749.7M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	12.8%	11.8%
Avg	6.9%	4.6%
Low	-0.3%	-2.6%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	3.94	4.17
Avg	3.35	3.56
Low	2.93	2.98

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	94.0%	24.4%
Avg	65.0%	6.3%
Low	44.3%	-11.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.